You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial

Citation Tools

Article menu
Metabolism
Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Yoneda M, Honda Y, Ogawa Y, et al
Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial
BMJ Open Diabetes Research and Care 2021;9:e001990. doi: 10.1136/bmjdrc-2020-001990